SL1009 (sodium dichloroacetate)

Name: SL1009 (sodium dichloroacetate) in Pyruvate dehydrogenase complex deficiency: Incidence of Pyruvate dehydrogenase complex deficiency
Published: 2026-09-14T15:39:06-04:00

Pyruvate dehydrogenase complex deficiency

Manufacturer: Saol Therapeutics
Regulatory submission: NDA resubmitted June 2026
Launch: Not announced
Last updated: September 19, 2026

Section

Product information and disease description Place of product in therapy Disease description Epidemiology

Incidence of Pyruvate dehydrogenase complex deficiency

1 evidence topic · 1 source

U.S. incidence estimate

“1 in 40,000 live births, approximately 90 newborns annually” (opens the source at this quote in a new tab)